secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zymeworks Inc. (ZYME)
CIK:        0001937653
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001193125-24-191535
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymeworks authorizes $60M share repurchase; initial $30M in H2 2024
-------------------------------------------------------------------

- Board authorized repurchase of up to $60M of common stock; initial $30M anticipated to begin promptly in second half of 2024.
- Remaining $30M reserved for future repurchases to maintain flexibility for market conditions and growth.
- Company expects existing cash plus regulatory milestone payments to fund planned operations into second half of 2027 despite repurchases.
- CEO Kenneth Galbraith cites confidence in pipeline and commitment to returning capital to shareholders, noting stock undervalued.
- Repurchases may be made in open market under Rule 10b5-1 and Rule 10b-18; program may be suspended or discontinued anytime.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937653/000119312524191535/0001193125-24-191535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937653/000119312524191535/d873250d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-191535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer